OPTIMATA LTD

20 Zichron Yaa'Kov St. – Tel Aviv – 6299920

VAT: IL512821802

http://www.optimata.com

Complicit EU Projects

Within the Horizon 2020 (2014-2020) framework, OPTIMATA LTD has received € 298,661.0 for its participation in a total of 3 project(s) with a total cost of € 13,208,986.

Start (YYYYMMDD)	Project ID	Project Name	Themes	End (YYYYMMDD)	Role	EC Contribution	Total Cost	IL Participation	Total Participation	CORDIS Link
2018-01-01	754923	COLOSSUS	gender equality · colorectal cancer · mutation · personalized medicine · employment	2023-06-30	participant	€ 38,361.6	€ 5,996,359	1	14	CORDIS ↪
2015-10-01	675448	TRAIN-ERS	inflammatory diseases · critical care medicine · melanoma · breast cancer · amyotrophic lateral sclerosis	2019-09-30	participant	€ 0.0	€ 3,628,756	1	18	CORDIS ↪
2014-12-01	642295	MEL-PLEX	drug discovery · melanoma · simulation software · mathematical model	2018-11-30	participant	€ 260,300.52	€ 3,583,870	2	20	CORDIS ↪

Showing 1 to 3 of 3 entries

OPTIMATA LTD did not participate in complicit projects under Horizon Europe (2021-2027).

Within the FP7 (2007-2013) framework, OPTIMATA LTD has received € 608,438.0 for its participation in a total of 2 project(s) with a total cost of € 26,959,610.

Start (YYYYMMDD)	Project ID	Project Name	Themes	End (YYYYMMDD)	Role	EC Contribution	Total Cost	IL Participation	Total Participation	CORDIS Link
2011-03-01	115156	DDMORE	ontology · software · public health · ecosystems · mathematical model	2016-08-31	participant	€ 147,278.0	€ 23,063,274	1	28	CORDIS ↪
2012-11-01	306021	APO-DECIDE	drug discovery · cell signaling · colorectal cancer · personalized medicine · pharmacokinetics	2014-10-31	participant	€ 461,160.0	€ 3,896,336	1	7	CORDIS ↪

Showing 1 to 2 of 2 entries